Considerations for powering a clinical proteomics study: Normal variability in the human plasma proteome.

Jackson, David; Herath, Athula; Swinton, Jonathan; Bramwell, David; Chopra, Rajesh; Hughes, Andrew; Cheeseman, Kevin; Tonge, Robert

Jackson, David; Herath, Athula; Swinton, Jonathan; Bramwell, David; Chopra, Rajesh; Hughes, Andrew; Cheeseman, Kevin; Tonge, Robert.

Afiliação

Jackson D; AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, UK. d.h.jackson@leeds.ac.uk.
Herath A; AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, UK.
Swinton J; AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, UK.
Bramwell D; Nonlinear Dynamics, Newcastle, UK.
Chopra R; AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, UK.
Hughes A; AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, UK.
Cheeseman K; AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, UK.
Tonge R; AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, UK.

Proteomics Clin Appl ; 3(3): 394-407, 2009 Mar.

Article em En | MEDLINE | ID: mdl-26238755

Palavras-chave

2D DIGE; Image analysis; Plasma; Statistical power; Variability

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Proteomics Clin Appl Assunto da revista: BIOQUIMICA Ano de publicação: 2009 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google